KVUE vs PG
KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories. PG: Global manufacturer and distributor of consumer staples—household, health and personal care products sold under iconic brands to over 180 countries.
Side-by-side fundamentals
| Metric | KVUE | PG | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $19.18 | $146.85 | |
| Market cap as of 2026-07-10 | $36.8B | $342.2B | |
| P/E as of 2026-07-10 | 22.70 | 20.59 | PG lower |
| PEG as of 2026-07-10 | 2.72 | 6.94 | KVUE lower |
| Net margin as of 2026-07-10 | +10.6% | +19.2% | PG higher |
| Gross margin as of 2026-07-10 | +58.9% | +50.9% | KVUE higher |
| Operating margin as of 2026-07-10 | +17.1% | +23.6% | PG higher |
| ROE as of 2026-07-10 | +15.2% | +31.2% | PG higher |
| ROA as of 2026-07-10 | +6.0% | +13.1% | PG higher |
| Debt / equity as of 2026-07-10 | 0.82 | 0.68 | PG lower |
| Revenue growth (YoY) as of 2026-07-10 | -0.1% | +3.3% | PG higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | +1.7% | PG higher |
| Dividend yield as of 2026-07-10 | +4.3% | +3.0% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 3 | 3 | Tie |
| Beta as of 2026-07-10 | 0.45 | 0.38 | |
| 1-year return as of 2026-07-09 close | -6.8% | -6.8% | PG higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.